The clinical pharmacokinetics of the novel antifolate N10-propargyl-5,8-dideazafolic acid (CB 3717).
Alison, D L
The clinical pharmacokinetics of the novel antifolate N10-propargyl-5,8-dideazafolic acid (CB 3717). [electronic resource] - Cancer chemotherapy and pharmacology 1985 - 265-71 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
0344-5704
10.1007/BF00258131 doi
Antineoplastic Agents--metabolism
Folic Acid--analogs & derivatives
Folic Acid Antagonists--metabolism
Humans
Kinetics
Liver--drug effects
Protein Binding
Quinazolines--metabolism
Tissue Distribution
The clinical pharmacokinetics of the novel antifolate N10-propargyl-5,8-dideazafolic acid (CB 3717). [electronic resource] - Cancer chemotherapy and pharmacology 1985 - 265-71 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
0344-5704
10.1007/BF00258131 doi
Antineoplastic Agents--metabolism
Folic Acid--analogs & derivatives
Folic Acid Antagonists--metabolism
Humans
Kinetics
Liver--drug effects
Protein Binding
Quinazolines--metabolism
Tissue Distribution